The knockdown of originally high ANXA1 expression has been assessed previously in cancer cell lines, showing suppressive effects on the viability and proliferation of glioma cells [15] and squamous cell lung cancer cells [16]. The gene discussed is ANXA1; the disease is central nervous system cancer.